MedCap AB (publ) (STO:MCAP)

Market Cap	6.89B +22.6%
Revenue (ttm)	2.11B +16.6%
Net Income	219.80M +6.0%
EPS	14.67 +4.8%
Shares Out	15.02M
PE Ratio	31.29
Forward PE	25.08
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,842
Average Volume	14,977
Open	459.50
Previous Close	459.00
Day's Range	454.00 - 473.00
52-Week Range	329.00 - 677.00
Beta	0.50
RSI	38.68
Earnings Date	Apr 29, 2026

About MedCap AB

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, pharmaceuticals, med tech and assistive tech companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Nordic region and Northern Europe. It typically invests between SEK25 millio...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 627
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MCAP

Financial Performance

In 2025, MedCap AB's revenue was 2.11 billion, an increase of 16.64% compared to the previous year's 1.81 billion. Earnings were 219.80 million, an increase of 5.98%.